Ocugen is trading at MXN 20.00, down 16.67%, with the immediate cause unclear.

  • The scheduled Citi 2026 Biopharma Back to School Conference presentation is set for September 9, 2026, from 3:40–4:15 p.m. EDT.
  • The Nasdaq Composite is down 0.71%, while oil above $100 and escalating U.S.-Iran tensions pressure risk sentiment.
  • Ocugen’s September 1 announcement that its first OCU410 Phase 3 patient had been dosed was prior positive pipeline news, not a same-day catalyst.